vs
信诺（CI）与HCA Healthcare（HCA）财务数据对比。点击上方公司名可切换其他公司
信诺的季度营收约是HCA Healthcare的3.8倍（$72.5B vs $19.1B），HCA Healthcare净利率更高（9.7% vs 1.8%，领先8.0%），信诺同比增速更快（10.4% vs 4.3%），过去两年信诺的营收复合增速更高（12.5% vs 4.5%）
信诺集团是总部位于美国康涅狄格州布卢姆菲尔德的跨国营利性医疗管理及保险企业。旗下保险子公司主营医疗、牙科、失能、人寿、意外保险及相关产品服务，多数产品通过雇主及其他团体渠道销售。
HCA Healthcare是1968年成立的美国营利性医疗服务运营商，总部位于田纳西州纳什维尔。截至2020年5月，其在全美20个州及英国运营186家医院，以及手术中心、独立急诊室、急症护理中心、医师诊所等约2400个各类医疗站点，业务覆盖范围广泛。
CI vs HCA — 直观对比
营收规模更大
CI
是对方的3.8倍
$19.1B
营收增速更快
CI
高出6.1%
4.3%
净利率更高
HCA
高出8.0%
1.8%
两年增速更快
CI
近两年复合增速
4.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $72.5B | $19.1B |
| 净利润 | $1.3B | $1.9B |
| 毛利率 | 20.3% | — |
| 营业利润率 | 3.2% | — |
| 净利率 | 1.8% | 9.7% |
| 营收同比 | 10.4% | 4.3% |
| 净利润同比 | -17.1% | 1.8% |
| 每股收益（稀释后） | $4.64 | $7.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIHCA
| Q1 26 | — | $19.1B | ||
| Q4 25 | $72.5B | $19.5B | ||
| Q3 25 | $69.7B | $19.2B | ||
| Q2 25 | $67.2B | $18.6B | ||
| Q1 25 | $65.5B | $18.3B | ||
| Q4 24 | $65.6B | $18.3B | ||
| Q3 24 | $63.7B | $17.5B | ||
| Q2 24 | $60.5B | $17.5B |
净利润CIHCA
| Q1 26 | — | $1.9B | ||
| Q4 25 | $1.3B | $1.9B | ||
| Q3 25 | $2.0B | $1.6B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.4B | $1.6B | ||
| Q4 24 | $1.5B | $1.4B | ||
| Q3 24 | $825.0M | $1.3B | ||
| Q2 24 | $1.6B | $1.5B |
毛利率CIHCA
| Q1 26 | — | — | ||
| Q4 25 | 20.3% | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.7% | — | ||
| Q1 25 | 26.1% | — | ||
| Q4 24 | 25.3% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 26.5% | — |
营业利润率CIHCA
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 13.7% | ||
| Q3 25 | 3.7% | 12.6% | ||
| Q2 25 | 3.4% | 13.0% | ||
| Q1 25 | 3.0% | 12.7% | ||
| Q4 24 | 3.3% | 11.7% | ||
| Q3 24 | 4.0% | 10.9% | ||
| Q2 24 | 4.0% | 12.8% |
净利率CIHCA
| Q1 26 | — | 9.7% | ||
| Q4 25 | 1.8% | 9.6% | ||
| Q3 25 | 2.8% | 8.6% | ||
| Q2 25 | 2.4% | 8.9% | ||
| Q1 25 | 2.2% | 8.8% | ||
| Q4 24 | 2.3% | 7.9% | ||
| Q3 24 | 1.3% | 7.3% | ||
| Q2 24 | 2.7% | 8.4% |
每股收益（稀释后）CIHCA
| Q1 26 | — | $7.15 | ||
| Q4 25 | $4.64 | $8.09 | ||
| Q3 25 | $6.98 | $6.96 | ||
| Q2 25 | $5.71 | $6.83 | ||
| Q1 25 | $4.85 | $6.45 | ||
| Q4 24 | $5.01 | $5.66 | ||
| Q3 24 | $2.63 | $4.88 | ||
| Q2 24 | $5.45 | $5.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.7B | $940.0M |
| 总债务越低越好 | $30.9B | — |
| 股东权益账面价值 | $41.7B | — |
| 总资产 | $157.9B | $19.3B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资CIHCA
| Q1 26 | — | $940.0M | ||
| Q4 25 | $8.7B | $1.0B | ||
| Q3 25 | $6.9B | $997.0M | ||
| Q2 25 | $5.1B | $939.0M | ||
| Q1 25 | $9.1B | $1.1B | ||
| Q4 24 | $8.2B | $1.9B | ||
| Q3 24 | $6.8B | $2.9B | ||
| Q2 24 | $7.9B | $831.0M |
总债务CIHCA
| Q1 26 | — | — | ||
| Q4 25 | $30.9B | $44.3B | ||
| Q3 25 | $30.9B | $42.6B | ||
| Q2 25 | $26.5B | $42.7B | ||
| Q1 25 | $26.5B | $44.6B | ||
| Q4 24 | $28.9B | $43.0B | ||
| Q3 24 | $30.2B | $43.0B | ||
| Q2 24 | $30.2B | $40.9B |
股东权益CIHCA
| Q1 26 | — | — | ||
| Q4 25 | $41.7B | $-6.0B | ||
| Q3 25 | $41.8B | $-5.3B | ||
| Q2 25 | $40.2B | $-4.4B | ||
| Q1 25 | $40.2B | $-3.5B | ||
| Q4 24 | $41.0B | $-2.5B | ||
| Q3 24 | $42.1B | $-2.2B | ||
| Q2 24 | $41.3B | $-1.6B |
总资产CIHCA
| Q1 26 | — | $19.3B | ||
| Q4 25 | $157.9B | $60.7B | ||
| Q3 25 | $157.9B | $59.7B | ||
| Q2 25 | $151.7B | $59.5B | ||
| Q1 25 | $150.7B | $59.8B | ||
| Q4 24 | $155.9B | $59.5B | ||
| Q3 24 | $157.6B | $59.5B | ||
| Q2 24 | $155.4B | $57.4B |
负债/权益比CIHCA
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.72× | — | ||
| Q2 24 | 0.73× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.1B | $2.0B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 4.83× | 1.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CIHCA
| Q1 26 | — | $2.0B | ||
| Q4 25 | $6.1B | $2.4B | ||
| Q3 25 | $3.4B | $4.4B | ||
| Q2 25 | $-1.9B | $4.2B | ||
| Q1 25 | $1.9B | $1.7B | ||
| Q4 24 | $5.2B | $2.6B | ||
| Q3 24 | $46.0M | $3.5B | ||
| Q2 24 | $265.0M | $2.0B |
自由现金流CIHCA
| Q1 26 | — | — | ||
| Q4 25 | — | $870.0M | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | — | $660.0M | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $690.0M |
自由现金流率CIHCA
| Q1 26 | — | — | ||
| Q4 25 | — | 4.5% | ||
| Q3 25 | — | 16.3% | ||
| Q2 25 | — | 16.3% | ||
| Q1 25 | — | 3.6% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 3.9% |
资本支出强度CIHCA
| Q1 26 | — | — | ||
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 6.3% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 7.3% |
现金转化率CIHCA
| Q1 26 | — | 1.08× | ||
| Q4 25 | 4.83× | 1.26× | ||
| Q3 25 | 1.73× | 2.69× | ||
| Q2 25 | -1.16× | 2.55× | ||
| Q1 25 | 1.36× | 1.03× | ||
| Q4 24 | 3.39× | 1.78× | ||
| Q3 24 | 0.06× | 2.77× | ||
| Q2 24 | 0.16× | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CI
| Network Pharmacy | $34.3B | 47% |
| Home Delivery And Specialty | $21.1B | 29% |
| Cigna Healthcare | $9.4B | 13% |
| Services | $4.5B | 6% |
| Other Pharmacy | $3.4B | 5% |
| Service Other | $144.0M | 0% |
HCA
暂无分部数据
